Indivior pays $600m in US opioid settlement

Indivior’s former parent company, Reckitt Benckiser, previously paid $1.4bn to resolve marketing claims related to Suboxone © Bloomberg

Indivior, the maker of an anti-addiction drug, has agreed to pay $600m to settle criminal and civil investigations and plead guilty to a felony charge, as part of the US Department of Justice’s largest ever resolution involving an opioid. 

Link to Original Story

Leave a Reply

Your email address will not be published. Required fields are marked *